Bedside MRI Opportunity Mammotome recently launched the Prima MR Dual Vacuum-Assisted system designed for bedside MRI-guided breast biopsy, signaling a potential sales angle with hospitals and imaging centers seeking in-room MRI capabilities to streamline procedures and reduce patient transfers.

Expansion Through Partnerships Strategic collaboration with Sirius Medical to distribute across the United States and Germany indicates a channel-focused growth path; sales efforts could target reseller relationships, co-marketing, and regional clinical training programs to accelerate market penetration.

Advanced Biopsy Portfolio Recent introductions such as AutoCore Single Insertion and HydroMark Plus site markers show a strong focus on next‑gen biopsy technology and marker accuracy, presenting opportunities to upsell to current customers adopting newer devices and consumables.

Global Reach + Education Headquartered in Cincinnati with distribution in over 50 countries and emphasis on educational resources suggests upsell potential in training packages, certification courses, and ongoing education subscriptions for clinical teams.

Financial Growth Signals Revenue in the tens of millions with a modest funding base indicates room for expanded procurement contracts, multi-year purchasing agreements, and bundled financing options to support larger hospital systems upgrading to premium biopsy solutions.